Bifidobacterium longum 1714 as a translational psychobiotic: modulation of stress, electrophysiology and neurocognition in healthy volunteers
Allen AP, Hutch W, Borre YE, Kennedy PJ, Temko A, Boylan G, Murphy E, Cryan JF, Dinan TG, Clarke G
Published in Translational Psychiatry
Abstract
Randomised placebo-controlled crossover trial of Bifidobacterium longum 1714 on stress, EEG and neurocognition.
Key Findings
B. longum 1714 reduced cumulative daily stress and subjective anxiety and improved hippocampus-dependent visuospatial memory relative to placebo in healthy volunteers.
Conclusions
A specific B. longum strain shows psychobiotic effects on stress and cognition in healthy adults.
Limitations
Small healthy-volunteer crossover trial; multiple exploratory endpoints; no clinical population.
Supplements Studied
B. longum 1714 reduced cumulative daily stress and subjective anxiety and improved hippocampus-dependent visuospatial memory relative to placebo in healthy volunteers.
Outcomes Measured
B. longum 1714 reduced cumulative daily stress and subjective anxiety and improved hippocampus-dependent visuospatial memory relative to placebo in healthy volunteers.
B. longum 1714 reduced cumulative daily stress and subjective anxiety and improved hippocampus-dependent visuospatial memory relative to placebo in healthy volunteers.
Related Health Concerns
Study Details
Access Study
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.